Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Better Buy: Amgen vs. Johnson & Johnson

TheMotleyFool

0 0

Better Buy: Amgen vs. Johnson & JohnsonPhoto, wide shot, wide-angle lens, Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png

If you're the kind of investor who likes to go big or go home, Amgen (NASDAQ: AMGN) and Johnson & Johnson (NYSE: JNJ) might be right up your alley. Amgen ranks as the biggest biotech in terms of market cap. Johnson & Johnson is the biggest healthcare company in the world.

Over the last 10 years, Amgen has delivered much greater returns for investors. But which healthcare stock is the better choice for the next decade? Here's how Amgen and J&J stack up against each other.

Image source: Getty Images.

Source Fool.com

Like: 0

JNJ

Teilen